Zimmer Biomet Holdings Inc

Healthcare · Medical Devices

94.30$ -2.6% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Income Statement

Zimmer Biomet Holdings Inc (ZBH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 8,232 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ZBH
Line item	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	861	939	1,041	1,179	1,372	1,901	2,981	3,286	3,495	3,898	4,121	4,095	4,220	4,452	4,472	4,623	4,673	5,998	7,668	7,803	7,933	7,982	6,128	6,827	6,940	7,394	7,679	8,232
Cost of Revenue	265	269	291	326	345	516	780	739	780	876	997	991	1,012	1,122	1,125	1,286	1,243	1,801	2,382	2,133	2,272	2,253	1,824	1,960	2,020	2,084	2,191	3,160
Gross Profit	596	670	750	853	1,028	1,385	2,201	2,547	2,715	3,022	3,124	3,105	3,208	3,330	3,347	3,337	3,431	4,197	5,287	5,670	5,661	5,730	4,303	4,867	4,920	5,310	5,487	5,072
Research & Development	36	45	52	72	81	106	167	176	188	210	192	206	219	238	226	204	192	269	366	370	392	449	323	436	406	459	437	459
Selling, General & Administrative	349	394	430	533	546	738	1,190	1,260	1,356	1,490	1,773	1,764	1,766	1,864	1,912	1,834	1,978	2,661	2,945	3,370	3,379	3,344	3,178	3,324	2,762	2,844	2,930	3,240
Total Operating Expenses	385	439	482	604	627	934	1,438	1,492	1,550	1,894	2,034	2,086	2,291	2,306	2,299	2,038	2,393	3,730	4,466	4,871	5,627	4,592	4,220	4,007	4,224	4,033	4,202	3,710
Operating Income	211	231	268	248	401	451	763	1,055	1,165	1,128	1,090	1,019	917	1,024	1,047	1,036	1,037	467	821	799	34	1,138	83	860	696	1,278	1,286	1,362
Interest Expense	0.0	0.0	0.0	7.4	12	139	194	128	8.9	216	32	21	60	55	73	70	63	287	355	325	289	227	212	208	165	201	218	293
Pre-Tax Income	211	231	268	241	389	438	732	1,041	1,169	1,132	1,122	998	860	979	990	981	939	153	400	465	-271	906	-105	499	404	1,067	1,037	831
Income Tax Expense	66	81	92	91	131	147	190	307	334	358	272	281	263	219	237	222	220	7.0	95	-1,349	108	-226	-96	54	112	42	131	126
Net Income	145	150	176	150	258	346	542	733	835	773	849	717	597	761	755	761	720	147	306	1,814	-379	1,132	-139	402	231	1,024	904	705
EBITDA	237	253	291	272	426	645	1,026	1,297	1,369	1,383	1,434	1,472	1,261	1,394	1,426	1,410	1,378	1,152	1,794	1,853	1,059	2,139	1,005	1,645	1,495	2,220	2,251	2,217

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings